↓ Skip to main content

3D Printing in Pharmaceutical and Medical Applications – Recent Achievements and Challenges

Overview of attention for article published in Pharmaceutical Research, July 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
4 X users
patent
4 patents

Citations

dimensions_citation
464 Dimensions

Readers on

mendeley
976 Mendeley
Title
3D Printing in Pharmaceutical and Medical Applications – Recent Achievements and Challenges
Published in
Pharmaceutical Research, July 2018
DOI 10.1007/s11095-018-2454-x
Pubmed ID
Authors

Witold Jamróz, Joanna Szafraniec, Mateusz Kurek, Renata Jachowicz

Abstract

Growing demand for customized pharmaceutics and medical devices makes the impact of additive manufacturing increased rapidly in recent years. The 3D printing has become one of the most revolutionary and powerful tool serving as a technology of precise manufacturing of individually developed dosage forms, tissue engineering and disease modeling. The current achievements include multifunctional drug delivery systems with accelerated release characteristic, adjustable and personalized dosage forms, implants and phantoms corresponding to specific patient anatomy as well as cell-based materials for regenerative medicine. This review summarizes the newest achievements and challenges of additive manufacturing in the field of pharmaceutical and biomedical research that have been published since 2015. Currently developed techniques of 3D printing are briefly described while comprehensive analysis of extrusion-based methods as the most intensively investigated is provided. The issue of printlets attributes, i.e. shape and size is described with regard to personalized dosage forms and medical devices manufacturing. The undeniable benefits of 3D printing are highlighted, however a critical view resulting from the limitations and challenges of the additive manufacturing is also included. The regulatory issue is pointed as well.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 976 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 976 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 132 14%
Student > Bachelor 112 11%
Student > Ph. D. Student 111 11%
Researcher 61 6%
Student > Doctoral Student 29 3%
Other 99 10%
Unknown 432 44%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 194 20%
Engineering 107 11%
Materials Science 33 3%
Chemistry 29 3%
Biochemistry, Genetics and Molecular Biology 28 3%
Other 106 11%
Unknown 479 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 March 2023.
All research outputs
#1,993,014
of 25,837,817 outputs
Outputs from Pharmaceutical Research
#68
of 3,104 outputs
Outputs of similar age
#39,750
of 342,084 outputs
Outputs of similar age from Pharmaceutical Research
#3
of 29 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,104 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,084 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.